PCF_SELECT

369 posts

PCF_SELECT banner
PCF_SELECT

PCF_SELECT

@PCF_select

Multidisciplinary team working together to develop, validate, and implement liquid biopsies to improve the lives of patients with prostate cancer.

Sumali Ekim 2016
43 Sinusundan411 Mga Tagasunod
PCF_SELECT nag-retweet
Michael Hofman
Michael Hofman@DrMHofman·
Clonal hematopoiesis (CH) in the @ANZUPtrials #TheraP study @ASCO #ASCO25 presented by Asli Munzur ■ ¹⁷⁷Lu-PSMA-617: higher incidence of emergent CH compared to cabazitaxel chemotherapy ■ Most new clonal hematopoiesis mutations ¹⁷⁷Lu-PSMA-617 fall in DNA damage repair response genes PPM1D, TP53, ATM, and CHEK2. ■ Clinical significance unclear but may become more relevant as radioligand therapy moves into earlier lines of treatment @ResearchWyatt @AzadOncology
Michael Hofman tweet mediaMichael Hofman tweet media
English
1
17
47
4.7K
PCF_SELECT nag-retweet
Bernard-Tessier
Bernard-Tessier@alicebernardt·
Just out today in @jclinicalinvest 🚀 mHSPC is not one disease, but a kaleidoscope of biological states. We highlight what we know — and the key gaps that remain — on the road to precision medicine✨ Led by my mentor @mishabeltran 🙌 #ProstateCancer #mHSPC #PrecisionOncology
Journal of Clinical Investigation@jclinicalinvest

Exploring the biology of metastatic hormone-sensitive #ProstateCancer: on the road to precision medicine In this Review, Alice Bernard-Tessier & Himisha Beltran @mishabeltran @danafarber discuss the underlying biology in mHSPC and highlight current knowledge gaps: doi.org/10.1172/JCI200…

English
1
7
27
5.3K
PCF_SELECT nag-retweet
Misha Beltran
Misha Beltran@mishabeltran·
Excited to share our new paper @NatureComms in collaboration with @RickmanLab, led by #RichaSingh @WeillCornell and @Bajji @DanaFarber #BeltranLab
Dana-Farber News@DanaFarberNews

New research published in @NatureComms provides critical mechanistic insights into how prostate cancer becomes resistant to treatment, uncovering how two key epigenetic mechanisms - DNA methylation and EZH2 activity - work together to drive transformation to a more aggressive form of the disease, neuroendocrine prostate cancer. @DanaFarber @bajji @mishabeltran Read more: bit.ly/4sk61bg

English
2
8
32
3.2K
PCF_SELECT nag-retweet
Michael Hofman
Michael Hofman@DrMHofman·
Stunning research from @EdmondMKwan on ctDNA in theranostics: 🧬Low ctDNA predicts better response with ¹⁷⁷Lu-PSMA-617 vs. cabazitaxel chemotherapy ⚠️PTEN alterations linked to worse outcomes on cabazitaxel 🧪ATM defects tied to favorable PSMA-617 results 🩻PET quantitative biomarkers (SUVmean) are additive 🌟We identify new candidate biomarkers for ¹⁷⁷Lu–PSMA-617 selection and ultimately expand the mCRPC predictive biomarker repertoire Online at @NatureMedicine nature.com/articles/s4159… @ANZUPtrials #TheraP @MovemberAUS @PCFA Support by @PCF_Science Challenge Award @ResearchWyatt @AzadOncology @Prof_IanD
Michael Hofman tweet mediaMichael Hofman tweet mediaMichael Hofman tweet mediaMichael Hofman tweet media
English
2
45
139
8.2K
PCF_SELECT nag-retweet
Francesca Demichelis
Francesca Demichelis@FrancescaBZNY·
Exciting work ahead on Large #Oncosomes at the @UniTrento @CIBIO_UniTrento with our team #DemichelisLab, Dolores Di Vizio @doldivizio at @CedarsSinai and Shannon Stott @svploeg at @MGH_RI funded by the @theNCI #PLUS
Cancer at Cedars-Sinai@CSCancerCenter

@doldivizio is the lead PI on the NCI grant ‘Phenotyping Large #Oncosomes for Ultimate Evaluation of Patients Status’ (PLUS) to develop a #prostatecancer liquid biopsy assay with co-PIs @FrancescaBZNY & @svploeg. Congratulations Dr. Di Vizio & team! @theNCI

English
0
5
32
2.5K
PCF_SELECT nag-retweet
Francesca Demichelis
Francesca Demichelis@FrancescaBZNY·
Proud of our LIG1 loss/PARP inhibition #SL study in @jclinicalinvest by @GiuliaFracassi_ an @AIRC_it fellowship awardee and @FraLo05 a @PCF_Science YIA Collaborators: @quimmateo @FdAdF66 Relevant to #prostatecancer and beyond. Download it! jci.org/articles/view/…
Giulia Fracassi@GiuliaFracassi_

🚨 New Preprint Alert! 🚨 I’m thrilled to share our latest study now online on JCI: 
CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancer. 🔬 Check out the preprint here: doi.org/10.1172/JCI179… Huge thanks to @FrancescaBZNY, @FraLo05, all Demichelis’ lab members and facilities staff at @UniTrento @CIBIO_UniTrento, and key collaborators @quimmateo, @FdAdF66 and Helmut Klocker. Special thanks to Fondazione Trentina per la Ricerca sui Tumori, @AIRC_it fellowship, @ERC_Research, @PCF_Science, and MIUR. #ProstateCancer #CRPC #LIG1 #PARPi #Biomarker #SyntheticLethality #PrecisionMedicine

English
1
10
29
3.6K
PCF_SELECT nag-retweet
Toni Choueiri, MD
Toni Choueiri, MD@DrChoueiri·
PROSTATE Paper 2 Franseschini et al. developed a targeted DNA methylation assay for the detection of neuroendocrine prostate cancer using plasma cell-free DNA with an AUC > 0.93. Their assay also quantifies tumor content and offers a phenotype evidence score, which reflects various CRPC phenotypes. @CD_AACR . Lead our own @mishabeltran @DanaFarber_GU aacrjournals.org/cancerdiscover…
Toni Choueiri, MD tweet mediaToni Choueiri, MD tweet media
English
1
8
21
3K
PCF_SELECT nag-retweet
Dougie Kass Private
Dougie Kass Private@DougKassPrivate·
💔😞 RIP, my friend @felixfengmd Please consider donating to the @AmericanCancer @ASTRO_org Felix Feng MD Clinician Scientist Grant Award. Let his incredible legacy live on. donate.cancer.org/g/tjjfqwdnrxrl…
Dougie Kass Private@DougKassPrivate

A man who deserved the two standing ovations regardless of his own cancer journey. @felixfengmd: “I just want to thank my friends” and “Behind every clinical trial is a patient like me. Thank you.” #PCFRetreat24

English
9
29
147
26.8K
PCF_SELECT nag-retweet
Toni Choueiri, MD
Toni Choueiri, MD@DrChoueiri·
Heartbroken💔we lost Dr. Felix Feng— close friend, selfless collaborator, brilliant scientist & a man who saved many prostate cancer lives with a triad of generosity, kindness, & teamwork. We miss you @felixfengmd --too early my friend. To all: please consider supporting this @ASTRO_org @AmericanCancer award in Felix name: donate.cancer.org/g/tjjfqwdnrxrl…?
Toni Choueiri, MD tweet mediaToni Choueiri, MD tweet media
English
3
19
137
15.9K
PCF_SELECT nag-retweet
Andrea Miyahira
Andrea Miyahira@AndreaMiyahira·
Felix was the best of us. I'm heartbroken by his passing.💔His spirit of generosity, kindness, humility, his humor, intelligence & scientific acumen - you made us better scientists & better people, Felix. Love & miss you always. My deepest condolences to @MaryFengMD & family.🙏♥️
Josh Lang@JoshLangMD

Tonight we sit with the cherished memories of a truly unforgettable individual who changed the lives of so many fighting cancer. Tomorrow we stand and get back to the fight against the terrible disease that took one of our best, brightest, and kindest. Love you forever, Felix.

English
2
13
85
9.7K
PCF_SELECT nag-retweet
PCF_SELECT nag-retweet
Dolores Di Vizio
Dolores Di Vizio@doldivizio·
A tremendous loss for the cancer scientific community. @felixfengmd truly was one of the very best. I feel fortunate to have had the chance to meet him. This is heartbreaking but I want to remember him with the smile that always lit up his face 💔@MaryFengMD 💔
Dolores Di Vizio tweet media
Josh Lang@JoshLangMD

Tonight we sit with the cherished memories of a truly unforgettable individual who changed the lives of so many fighting cancer. Tomorrow we stand and get back to the fight against the terrible disease that took one of our best, brightest, and kindest. Love you forever, Felix.

English
1
12
57
4.1K